The Journal of Neuroscience, February 18, 2009, 29(7):1987-1997; doi:10.1523/JNEUROSCI.4072-08.2009
Previous Article | Next Article 
Neurobiology of Disease
Polyglutamine-Expanded Androgen Receptor Truncation Fragments Activate a Bax-Dependent Apoptotic Cascade Mediated by DP5/Hrk
Jessica E. Young,1 *
Gwenn A. Garden,2,5 *
Refugio A. Martinez,1
Fumiaki Tanaka,6
C. Miguel Sandoval,6
Annette C. Smith,1
Bryce L. Sopher,1
Amy Lin,7
Kenneth H. Fischbeck,6
Lisa M. Ellerby,7
Richard S. Morrison,3,5
J. Paul Taylor,8 and
Albert R. La Spada1,2,4,5
Departments of 1Laboratory Medicine, 2Neurology, 3Neurological Surgery, and 4Medicine, and 5Center for Neurogenetics and Neurotherapeutics, University of Washington, Seattle, Washington 98195-7110, 6Neurogenetics Branch, National Institute of Neurological Disorders and Stroke–National Institutes of Health, Bethesda, Maryland 20892, 7Buck Institute for Age Research, Novato, California 94945, and 8Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Correspondence should be addressed to Dr. Albert R. La Spada, Department of Laboratory Medicine, University of Washington Medical Center, Box 357110, Room NW 120, Seattle, WA 98195-7110. Email: laspada{at}u.washington.edu
Spinal and bulbar muscular atrophy (SBMA) is an inherited neuromuscular disorder caused by a polyglutamine (polyQ) repeat expansion in the androgen receptor (AR). PolyQ-AR neurotoxicity may involve generation of an N-terminal truncation fragment, as such peptides occur in SBMA patients and mouse models. To elucidate the basis of SBMA, we expressed N-terminal truncated AR in motor neuron-derived cells and primary cortical neurons. Accumulation of polyQ-AR truncation fragments in the cytosol resulted in neurodegeneration and apoptotic, caspase-dependent cell death. Using primary neurons from mice transgenic or deficient for apoptosis-related genes, we determined that polyQ-AR apoptotic activation is fully dependent on Bax. Jun N-terminal kinase (JNK) was required for apoptotic pathway activation through phosphorylation of c-Jun. Expression of polyQ-AR in DP5/Hrk null neurons yielded significant protection against apoptotic activation, but absence of Bim did not provide protection, apparently due to compensatory upregulation of DP5/Hrk or other BH3-only proteins. Misfolded AR protein in the cytosol thus initiates a cascade of events beginning with JNK and culminating in Bax-dependent, intrinsic pathway activation, mediated in part by DP5/Hrk. As apoptotic mediators are candidates for toxic fragment generation and other cellular processes linked to neuron dysfunction, delineation of the apoptotic activation pathway induced by polyQ-expanded AR may shed light on the pathogenic cascade in SBMA and other motor neuron diseases.
Key words: polyglutamine; spinal and bulbar muscular atrophy; truncation; apoptosis; Bax; DP5
Received Aug. 26, 2008;
revised Nov. 26, 2008;
accepted Dec. 31, 2008.
Correspondence should be addressed to Dr. Albert R. La Spada, Department of Laboratory Medicine, University of Washington Medical Center, Box 357110, Room NW 120, Seattle, WA 98195-7110. Email: laspada{at}u.washington.edu